carvedilol has been researched along with Cell Transformation, Neoplastic in 3 studies
Cell Transformation, Neoplastic: Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M | 1 |
| Liang, S | 2 |
| Shahid, A | 1 |
| Andresen, BT | 2 |
| Huang, Y | 2 |
| Ma, Z | 1 |
| Liu, X | 1 |
| Zhang, Q | 1 |
| Yu, Z | 1 |
| Gao, D | 1 |
| Cleveland, KH | 1 |
| Chang, A | 1 |
| Huang, KM | 1 |
| Chen, S | 1 |
| Guo, L | 1 |
3 other studies available for carvedilol and Cell Transformation, Neoplastic
| Article | Year |
|---|---|
The β-Blocker Carvedilol Prevented Ultraviolet-Mediated Damage of Murine Epidermal Cells and 3D Human Reconstructed Skin.
Topics: Adrenergic beta-Antagonists; Animals; Carvedilol; Cell Culture Techniques; Cell Transformation, Neop | 2020 |
Carvedilol suppresses malignant proliferation of mammary epithelial cells through inhibition of the ROS‑mediated PI3K/AKT signaling pathway.
Topics: Antioxidants; Benzo(a)pyrene; Breast; Breast Neoplasms; Carvedilol; Cell Line; Cell Proliferation; C | 2019 |
Carvedilol inhibits EGF-mediated JB6 P+ colony formation through a mechanism independent of adrenoceptors.
Topics: Adrenergic beta-Antagonists; Alprenolol; Animals; Carvedilol; Cell Line; Cell Proliferation; Cell Tr | 2019 |